Madrigal Pharmaceuticals, Inc. (MDGL) DCF Valuation

Valoración de DCF de Madrigal Pharmaceuticals, Inc. (MDGL)

US | Healthcare | Biotechnology | NASDAQ
Madrigal Pharmaceuticals, Inc. (MDGL) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Madrigal Pharmaceuticals, Inc. (MDGL) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Mejore sus estrategias de inversión con la calculadora DCF de Madrigal Pharmaceuticals, Inc. (MDGL)! Explore datos financieros genuinos, ajuste las predicciones y gastos de crecimiento, y observe instantáneamente cómo estas alteraciones influyen en el valor intrínseco de los productos farmacéuticos madrigales (MDGL).


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -94.9 -206.2 -242.1 -293.1 -380.0 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .1 .5 .4 .5 .5 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -95.0 -206.7 -242.5 -293.6 -380.5 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 439.0 284.1 270.3 358.8 634.1 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable 1.2 1.0 21.4 23.8 28.0 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -.2 -.3 -.2 -.2 -1.5 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -82.4 -201.8 -241.7 -297.5 -380.5 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -81.3 -201.8 -221.2 -294.8 -377.2 -28.0 .0 .0 .0 .0
WACC, % 5.47 5.5 5.5 5.5 5.5 5.49 5.49 5.49 5.49 5.49
PV UFCF
SUM PV UFCF -26.6
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -27
Net Debt 17
Equity Value -44
Diluted Shares Outstanding, MM 19
Equity Value Per Share -2.35

What You Will Get

  • Real MDGL Financials: Access to historical and projected data for precise valuation.
  • Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
  • Automated Calculations: Intrinsic value and NPV are computed in real-time.
  • Scenario Analysis: Evaluate various scenarios to assess Madrigal Pharmaceuticals' future outlook.
  • Clear and User-Friendly Design: Designed for professionals while remaining easy for newcomers.

Key Features

  • 🔍 Real-Life MDGL Financials: Pre-filled historical and projected data for Madrigal Pharmaceuticals, Inc.
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Madrigal's intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Madrigal’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  1. Step 1: Download the Excel file for Madrigal Pharmaceuticals, Inc. (MDGL).
  2. Step 2: Review Madrigal’s pre-filled financial data and forecasts.
  3. Step 3: Modify key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Observe the DCF model update in real-time as you adjust your assumptions.
  5. Step 5: Evaluate the outputs and leverage the results for your investment decisions.

Why Choose This Calculator for Madrigal Pharmaceuticals, Inc. (MDGL)?

  • Comprehensive Tool: Offers DCF, WACC, and financial ratio analyses tailored for Madrigal Pharmaceuticals.
  • Customizable Inputs: Modify yellow-highlighted cells to explore different financial scenarios for MDGL.
  • Detailed Insights: Automatically computes Madrigal’s intrinsic value and Net Present Value for informed decision-making.
  • Preloaded Data: Access to historical and projected data ensures reliable starting points for analysis.
  • Professional Quality: Perfect for financial analysts, investors, and business consultants focusing on MDGL.

Who Should Use This Product?

  • Investors: Evaluate Madrigal Pharmaceuticals' valuation before making stock transactions.
  • CFOs and Financial Analysts: Optimize valuation processes and assess financial forecasts.
  • Startup Founders: Understand the valuation methods applied to biopharmaceutical companies like Madrigal.
  • Consultants: Provide detailed valuation reports for clients in the healthcare sector.
  • Students and Educators: Utilize real-world case studies to learn and teach valuation strategies.

What the Template Contains

  • Historical Data: Includes Madrigal Pharmaceuticals' past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Madrigal Pharmaceuticals' intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Madrigal Pharmaceuticals' financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.